News

With the delivery of a 40-ton piece of high-tech equipment today, the Stephenson Cancer Center welcomed the newest FDA-approved proton therapy system to Oklahoma. Mevion Medical Systems delivered the Proton Therapy System as part of the final phase of installation at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center. "We are pleased to receive this revolutionary technology and to add this innovative proton therapy system to the expansive list of cancer services available at the Stephenson Cancer Center,” said OU President David L. Boren.

Read more >

A National Cancer Institute clinical trial conducted at the Stephenson Cancer Center and other sites in the U.S. and Spain brings new hope to patients with advanced cervical cancer in the form of a life-extending treatment option. The Stephenson Cancer Center was one of the top two enrolling sites for the clinical trial that involved 452 patients.

Read more >

A $528,000 grant will help researchers with the Stephenson Cancer Center at the University of Oklahoma explore a promising, new treatment for bladder cancer, the fourth most common cancer in men. The Research Scholar Grant was awarded by the American Cancer Society to Youngjae You, Ph.D., a Cancer Center member and associate professor in the OU College of Pharmacy’s Department of Pharmaceutical Sciences.

Read more >